Form D · Other
Time Therapeutics Inc.
New York, NY · CIK 0001745531
Offering snapshot reported Jul 2, 2024 · SEC filing
- Reported sold
- $12.8M Offering amount: $15M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 20, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 2, 2024 | Initial | $12,800,000 | No comparison | 5 | SEC filing |
| Jul 28, 2023 | Amendment | $7,800,000 | $7,350,000vs Feb 8, 2022 | 5 | SEC filing |
| Feb 8, 2022 | Initial | $450,000 | No comparison | 3 | SEC filing |
| Apr 23, 2021 | Initial | $595,000 | No comparison | 9 | SEC filing |
| Sep 30, 2020 | Initial | $4,999,981 | No comparison | 13 | SEC filing |
| Sep 14, 2020 | Initial | $58,500 | No comparison | 6 | SEC filing |
| Sep 14, 2020 | Amendment | $2,389,176 | $2,239,176vs Jul 5, 2018 | 25 | SEC filing |
| Jul 5, 2018 | Initial | $150,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-517615
Source: Form D, filed Jul 2, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mohammad Saad Alam | Director, Executive |
| Stuart Blitz | Director, Executive |
| Theodore Maidenberg | Director |
Issuer details
Industry: Other (See others in industry)
Address:
154 West 14th Street, Suite 6 110
New York, NY, 10010
New York, NY, 10010